Ontology type: schema:ScholarlyArticle Open Access: True
2019-12-20
AUTHORSBrian I. Rini, Dena Battle, Robert A. Figlin, Daniel J. George, Hans Hammers, Tom Hutson, Eric Jonasch, Richard W. Joseph, David F. McDermott, Robert J. Motzer, Sumanta K. Pal, Allan J. Pantuck, David I. Quinn, Virginia Seery, Martin H. Voss, Christopher G. Wood, Laura S. Wood, Michael B. Atkins
ABSTRACTThe approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with advanced renal cell carcinoma (aRCC). Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor monoclonal antibody, was approved as monotherapy in 2015 for aRCC after treatment with a VEGF-targeting agent. In April 2018, the combination of nivolumab and ipilimumab, a CTLA-4 inhibitor, was approved for intermediate- and poor-risk, previously untreated patients with aRCC. Then, in 2019, combinations therapies consisting of pembrolizumab (anti-PD-1) or avelumab (anti-PD-ligand (L) 1) with axitinib (a VEGF receptor tyrosine kinase inhibitor) were also approved to treat aRCC and are likely to produce dramatic shifts in the therapeutic landscape. To address the rapid advances in immunotherapy options for patients with aRCC, the Society for Immunotherapy of Cancer (SITC) reconvened its Cancer Immunotherapy Guidelines (CIG) Renal Cell Carcinoma Subcommittee and tasked it with generating updated consensus recommendations for the treatment of patients with this disease. More... »
PAGES354
http://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8
DOIhttp://dx.doi.org/10.1186/s40425-019-0813-8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1123532586
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/31856918
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Immunology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents, Immunological",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomarkers, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma, Renal Cell",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease Management",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Immunotherapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Kidney Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Molecular Targeted Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Staging",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Practice Guidelines as Topic",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA",
"id": "http://www.grid.ac/institutes/grid.239578.2",
"name": [
"Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA"
],
"type": "Organization"
},
"familyName": "Rini",
"givenName": "Brian I.",
"id": "sg:person.01113325143.17",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113325143.17"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "KCCure, Leesburg, VA, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"KCCure, Leesburg, VA, USA"
],
"type": "Organization"
},
"familyName": "Battle",
"givenName": "Dena",
"id": "sg:person.012255146260.77",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012255146260.77"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cedars-Sinai Medical Center, Los Angeles, CA, USA",
"id": "http://www.grid.ac/institutes/grid.50956.3f",
"name": [
"Cedars-Sinai Medical Center, Los Angeles, CA, USA"
],
"type": "Organization"
},
"familyName": "Figlin",
"givenName": "Robert A.",
"id": "sg:person.0664152550.77",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664152550.77"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Duke University School of Medicine, Durham, NC, USA",
"id": "http://www.grid.ac/institutes/grid.26009.3d",
"name": [
"Duke University School of Medicine, Durham, NC, USA"
],
"type": "Organization"
},
"familyName": "George",
"givenName": "Daniel J.",
"id": "sg:person.013110637342.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013110637342.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "UT Southwestern, Dallas, TX, USA",
"id": "http://www.grid.ac/institutes/grid.267313.2",
"name": [
"UT Southwestern, Dallas, TX, USA"
],
"type": "Organization"
},
"familyName": "Hammers",
"givenName": "Hans",
"id": "sg:person.01220204543.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220204543.52"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Charles A. Sammons Cancer Center, Baylor, Dallas, TX, USA",
"id": "http://www.grid.ac/institutes/grid.39382.33",
"name": [
"Charles A. Sammons Cancer Center, Baylor, Dallas, TX, USA"
],
"type": "Organization"
},
"familyName": "Hutson",
"givenName": "Tom",
"type": "Person"
},
{
"affiliation": {
"alternateName": "MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Jonasch",
"givenName": "Eric",
"id": "sg:person.01172764022.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172764022.37"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Mayo Clinic, Jacksonville, FL, USA",
"id": "http://www.grid.ac/institutes/grid.417467.7",
"name": [
"Mayo Clinic, Jacksonville, FL, USA"
],
"type": "Organization"
},
"familyName": "Joseph",
"givenName": "Richard W.",
"id": "sg:person.0630150147.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630150147.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Beth Israel Deaconess Medical Center, Boston, MA, USA",
"id": "http://www.grid.ac/institutes/grid.239395.7",
"name": [
"Beth Israel Deaconess Medical Center, Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "McDermott",
"givenName": "David F.",
"id": "sg:person.0656541200.82",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656541200.82"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Memorial Sloan-Kettering Cancer Center, New York, NY, USA",
"id": "http://www.grid.ac/institutes/grid.51462.34",
"name": [
"Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
],
"type": "Organization"
},
"familyName": "Motzer",
"givenName": "Robert J.",
"id": "sg:person.01234500340.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234500340.18"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City of Hope, Duarte, CA, USA",
"id": "http://www.grid.ac/institutes/grid.410425.6",
"name": [
"City of Hope, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Pal",
"givenName": "Sumanta K.",
"id": "sg:person.01162002222.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162002222.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "UCLA School of Medicine, Los Angeles, CA, USA",
"id": "http://www.grid.ac/institutes/grid.19006.3e",
"name": [
"UCLA School of Medicine, Los Angeles, CA, USA"
],
"type": "Organization"
},
"familyName": "Pantuck",
"givenName": "Allan J.",
"id": "sg:person.01365327543.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365327543.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Norris Comprehensive Cancer Center, Los Angeles, CA, USA",
"id": "http://www.grid.ac/institutes/grid.42505.36",
"name": [
"Norris Comprehensive Cancer Center, Los Angeles, CA, USA"
],
"type": "Organization"
},
"familyName": "Quinn",
"givenName": "David I.",
"id": "sg:person.01013134010.15",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Beth Israel Deaconess Medical Center, Boston, MA, USA",
"id": "http://www.grid.ac/institutes/grid.239395.7",
"name": [
"Beth Israel Deaconess Medical Center, Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "Seery",
"givenName": "Virginia",
"id": "sg:person.01330202470.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330202470.13"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Memorial Sloan-Kettering Cancer Center, New York, NY, USA",
"id": "http://www.grid.ac/institutes/grid.51462.34",
"name": [
"Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
],
"type": "Organization"
},
"familyName": "Voss",
"givenName": "Martin H.",
"id": "sg:person.0577111044.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577111044.36"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Wood",
"givenName": "Christopher G.",
"id": "sg:person.01040121722.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA",
"id": "http://www.grid.ac/institutes/grid.239578.2",
"name": [
"Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA"
],
"type": "Organization"
},
"familyName": "Wood",
"givenName": "Laura S.",
"id": "sg:person.010243623117.05",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010243623117.05"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Georgetown, Lombardi Comprehensive Cancer Center, Research Building, Room E501 3970 Reservoir Road NW, 20057, Washington, DC, USA",
"id": "http://www.grid.ac/institutes/grid.213910.8",
"name": [
"Georgetown, Lombardi Comprehensive Cancer Center, Research Building, Room E501 3970 Reservoir Road NW, 20057, Washington, DC, USA"
],
"type": "Organization"
},
"familyName": "Atkins",
"givenName": "Michael B.",
"id": "sg:person.010266621557.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010266621557.13"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/nrclinonc.2013.153",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042806557",
"https://doi.org/10.1038/nrclinonc.2013.153"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12032-018-1147-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1103813735",
"https://doi.org/10.1007/s12032-018-1147-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s40425-016-0180-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048113477",
"https://doi.org/10.1186/s40425-016-0180-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s40425-014-0035-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011546195",
"https://doi.org/10.1186/s40425-014-0035-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s40425-019-0522-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1112212877",
"https://doi.org/10.1186/s40425-019-0522-3"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s40425-018-0319-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1100689551",
"https://doi.org/10.1186/s40425-018-0319-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41591-018-0053-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1104306675",
"https://doi.org/10.1038/s41591-018-0053-3"
],
"type": "CreativeWork"
}
],
"datePublished": "2019-12-20",
"datePublishedReg": "2019-12-20",
"description": "The approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with advanced renal cell carcinoma (aRCC). Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor monoclonal antibody, was approved as monotherapy in 2015 for aRCC after treatment with a VEGF-targeting agent. In April 2018, the combination of nivolumab and ipilimumab, a CTLA-4 inhibitor, was approved for intermediate- and poor-risk, previously untreated patients with aRCC. Then, in 2019, combinations therapies consisting of pembrolizumab (anti-PD-1) or avelumab (anti-PD-ligand (L) 1) with axitinib (a VEGF receptor tyrosine kinase inhibitor) were also approved to treat aRCC and are likely to produce dramatic shifts in the therapeutic landscape. To address the rapid advances in immunotherapy options for patients with aRCC, the Society for Immunotherapy of Cancer (SITC) reconvened its Cancer Immunotherapy Guidelines (CIG) Renal Cell Carcinoma Subcommittee and tasked it with generating updated consensus recommendations for the treatment of patients with this disease.",
"genre": "article",
"id": "sg:pub.10.1186/s40425-019-0813-8",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1049249",
"issn": [
"2051-1426"
],
"name": "Journal for ImmunoTherapy of Cancer",
"publisher": "BMJ",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "7"
}
],
"keywords": [
"advanced renal cell carcinoma",
"renal cell carcinoma",
"treatment of patients",
"cell carcinoma",
"immune checkpoint inhibitor monoclonal antibodies",
"combination of nivolumab",
"Cancer consensus statement",
"CTLA-4 inhibitors",
"immunotherapy of cancer",
"untreated patients",
"immunotherapy options",
"immunotherapeutic agents",
"combination therapy",
"consensus statement",
"consensus recommendations",
"patients",
"therapeutic landscape",
"immunotherapy",
"monoclonal antibodies",
"nivolumab",
"carcinoma",
"treatment",
"combination strategies",
"ipilimumab",
"monotherapy",
"axitinib",
"therapy",
"agents",
"cancer",
"disease",
"antibodies",
"VEGF",
"inhibitors",
"approval",
"options",
"years",
"recommendations",
"Subcommittee",
"dramatic shift",
"rapid advances",
"recent years",
"advances",
"combination",
"strategies",
"society",
"statements",
"shift",
"landscape"
],
"name": "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)",
"pagination": "354",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1123532586"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s40425-019-0813-8"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"31856918"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s40425-019-0813-8",
"https://app.dimensions.ai/details/publication/pub.1123532586"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:21",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_808.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/s40425-019-0813-8"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8'
This table displays all metadata directly associated to this object as RDF triples.
338 TRIPLES
22 PREDICATES
92 URIs
76 LITERALS
17 BLANK NODES